Arno's Mattes Discusses Development of Onapristone (Audio)

Glenn Mattes, president and chief executive officer at Arno Therapeutics Inc., discusses biotech company's development of the oncology drug onapristone. Mattes talked with Bloomberg's Pimm Fox and Carol Massar on Bloomberg Radio's "Taking Stock" on November 19th.

(Source: Bloomberg)

Running time 07:09

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.